Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults

NCT03265288 is registered in ClinicalTrials.gov with Laurent Pharmaceuticals Inc. as lead sponsor.

NCT NCT03265288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03265288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Lead sponsor
Laurent Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 5, 2018
Completion date
September 15, 2021
Enrollment
166 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis